Compounds > 1-phenyl-2-decanoylamino-3-morpholino-1-propanol

1-phenyl-2-decanoylamino-3-morpholino-1-propanol and g(m2) ganglioside

1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with g(m2) ganglioside in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Butters, TD; Dwek, RA; Jeyakumar, M; Platt, FM	1

Reviews

1 review(s) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and g(m2) ganglioside

Article	Year
Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis. Neuropathology and applied neurobiology, 2002, Volume: 28, Issue:5 Topics: 1-Deoxynojirimycin; Animals; Bone Marrow Transplantation; Chemotherapy, Adjuvant; Disease Models, Animal; G(M2) Ganglioside; Gangliosides; Glucosylceramides; Glucosyltransferases; Glycosphingolipids; Humans; Lysosomal Storage Diseases; Lysosomes; Mice; Models, Biological; Models, Chemical; Morpholines; Sandhoff Disease; Tay-Sachs Disease; Treatment Outcome	2002

Article

Year

Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.

Neuropathology and applied neurobiology, 2002, Volume: 28, Issue:5

Topics: 1-Deoxynojirimycin; Animals; Bone Marrow Transplantation; Chemotherapy, Adjuvant; Disease Models, Animal; G(M2) Ganglioside; Gangliosides; Glucosylceramides; Glucosyltransferases; Glycosphingolipids; Humans; Lysosomal Storage Diseases; Lysosomes; Mice; Models, Biological; Models, Chemical; Morpholines; Sandhoff Disease; Tay-Sachs Disease; Treatment Outcome

2002